Business Context and Reporting Period
Company: XpresSpa Group, Inc. (Note: Metadata referenced "XWELL, Inc." but the filing identifies the registrant as XpresSpa Group, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: July 8, 2019
Context: The Company entered into multiple material definitive agreements on July 8, 2019, involving new debt financing, amendments to existing credit facilities, and restructuring of preferred stock and warrant terms. These transactions require shareholder approval for certain equity conversions and price reductions.
Key Financial Metrics and Capital Structure
This filing details capital structure changes rather than operating performance metrics (revenue, profit, cash flow) for a specific period. Key financial terms include:
- New Debt (Calm Notes): $2,500,000 principal amount, 5.00% unsecured convertible notes due May 31, 2022.
- Amended Debt (B3D Note): Principal increased to $7,000,000; interest rate reduced to 9.00%; maturity extended to May 31, 2021.
- Warrants Issued: 937,500 warrants to purchase common stock at $2.00 per share (Calm Warrants).
- Preferred Stock:
- Series E: Authorized shares increased to 2,397,060; conversion price proposed reduction to $2.00.
- Series D: Conversion price proposed reduction to $2.00; automatic conversion to common stock proposed.
- Series F: New class established; 9,000 shares issued; conversion price $2.00 per share.
- Series B: Authorized shares eliminated (reduced to zero).
- Liquidity: The Company expects to receive $2,500,000 in gross proceeds from the Calm Private Placement upon closing.
Material Changes Versus Prior Period
The filing represents a significant restructuring of the Company's capitalization table and debt obligations compared to the prior period:
- Debt Restructuring: The B3D credit facility was amended to increase the principal obligation by an unspecified amount to reach $7.0 million and lower the interest rate from a previous higher rate to 9.0%.
- Equity Dilution Potential: Multiple instruments (Notes, Warrants, Preferred Stock) were aligned to a $2.00 conversion/exercise price, subject to shareholder approval, potentially increasing the number of shares issuable upon conversion.
- Collaboration: Entered into an Amended and Restated Product Sale and Marketing Agreement with Calm.com, Inc., extending the term to July 31, 2021, with automatic six-month renewals.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook:
- The Company intends to close the Calm Private Placement as soon as possible following the signing of transaction documents.
- Management plans to hold a stockholder meeting within 120 days of the closing date to seek approval for the issuance of shares and price reductions.
- Shareholder Approval: Critical terms, including the conversion of Series E and D preferred stock, the reduction of conversion prices to $2.00, and the issuance of shares upon conversion of the Calm and B3D notes, are contingent upon shareholder approval.
- Registration Rights: The Company must file Form S-3 registration statements for the underlying shares within 45 days of issuance; failure to do so may result in liquidated damages.
- Covenants: The Calm Notes include negative covenants prohibiting new indebtedness, liens, dividends, and variable rate transactions until Calm holds less than 10% of the notes.
- Prepayment Penalties: Early prepayment of the B3D Note may incur a premium of 4% or the Black Scholes value of the prepaid amount.
- Interest on Calm Notes is payable in arrears quarterly and may be paid in cash or Series E Preferred Stock.
- Interest on B3D Notes is deferred and compounded monthly until the earlier of 90 days post-amendment or receipt of shareholder approval.
Important Facts for Investor Verification
- Verify the status of the shareholder meeting scheduled within 120 days to approve the $2.00 conversion price reductions and share issuances.
- Confirm the closing date of the Calm Private Placement and the receipt of the $2.5 million gross proceeds.
- Monitor the filing of the Form S-3 registration statements for Calm and B3D underlying shares within the 45-day window to avoid liquidated damages.
- Review the impact of the increased B3D principal ($7.0 million) and the 9.0% interest rate on future cash flow obligations.
- Check for any subsequent filings regarding the elimination of Series B Preferred Stock and the issuance of Series F Preferred Stock.